Northern Trust’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Sell |
300,321
-9,866
| -3% | -$66.3K | ﹤0.01% | 2982 |
|
|
2025
Q1 | $2.8M | Sell |
310,187
-7,990
| -3% | -$72.2K | ﹤0.01% | 2742 |
|
|
2024
Q4 | $5.5M | Buy |
318,177
+70,497
| +28% | +$1.22M | ﹤0.01% | 2455 |
|
|
2024
Q3 | $3.96M | Buy |
247,680
+57,371
| +30% | +$917K | ﹤0.01% | 2614 |
|
|
2024
Q2 | $2.71M | Sell |
190,309
-9,033
| -5% | -$129K | ﹤0.01% | 2742 |
|
|
2024
Q1 | $2.82M | Sell |
199,342
-1,346
| -0.7% | -$19.1K | ﹤0.01% | 2786 |
|
|
2023
Q4 | $3.03M | Sell |
200,688
-4,373
| -2% | -$66K | ﹤0.01% | 2771 |
|
|
2023
Q3 | $3.24M | Buy |
205,061
+10,967
| +6% | +$173K | ﹤0.01% | 2678 |
|
|
2023
Q2 | $2.94M | Buy |
194,094
+160,701
| +481% | +$2.43M | ﹤0.01% | 2791 |
|
|
2023
Q1 | $484K | Sell |
33,393
-967
| -3% | -$14K | ﹤0.01% | 3479 |
|
|
2022
Q4 | $465K | Buy |
34,360
+4,363
| +15% | +$59K | ﹤0.01% | 3532 |
|
|
2022
Q3 | $473K | Buy |
29,997
+13,669
| +84% | +$216K | ﹤0.01% | 3538 |
|
|
2022
Q2 | $199K | Sell |
16,328
-73,930
| -82% | -$901K | ﹤0.01% | 3930 |
|
|
2022
Q1 | $847K | Buy |
90,258
+10,775
| +14% | +$101K | ﹤0.01% | 3505 |
|
|
2021
Q4 | $1.36M | Buy |
+79,483
| New | +$1.36M | ﹤0.01% | 3413 |
|